<DOC>
	<DOCNO>NCT02732054</DOCNO>
	<brief_summary>This study aim evaluate efficacy different hepatitis B vaccination regimens HIV-infected adult low CD4 cell count northern Thailand .</brief_summary>
	<brief_title>Hepatitis B Vaccination HIV-infected Adults With Low CD4 Cell Counts</brief_title>
	<detailed_description>HIV-infected adult CD4+ cell count &lt; 200 cells/mm3 , undetectable plasma HIV-1 RNA , negative HBV marker randomly assign receive one 2 regimen recombinant hepatitis B vaccine ( Centro De Ingenieria Genetica Y Biotecnologia , La Habana , Cuba ) ; 1 ) 20 μg IM month 0 , 1 , 6 ( 3-standard dos group ) , 2 ) 20 μg IM month 0 , 1 , 2 , 6 ( 4-standard dos group ) . This study aim evaluate efficacy safety 2 hepatitis B vaccination regimens month 7 vaccination .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . HIVinfection 2 . ≥18 year old 3 . Received combination antiretroviral therapy least 1 year 4 . Had CD4+ cell count &lt; 200 cells/mm3 least 1 year 5 . Undetectable plasma HIV1 RNA least 1 year 6 . Negative hepatitis B surface antigen ( HBsAg ) , antibody hepatitis B surface antigen ( antiHBs ) , antibody hepatitis B core antigen ( antiHBc ) , 7 . Had history previous HBV vaccine 8 . Negative antibody hepatitis C virus ( antiHCV ) 9 . No active opportunistic infection ( time screen ) 10 . Willing sign inform consent 11 . Able return followup . Exclusion criteria 1 . Pregnancy lactation 2 . History hypersensitivity component vaccine 3 . Active malignancy receive chemotherapy radiation , immunocompromised condition besides HIV ( e.g. , solid organ transplant ) , receive immunosuppressive ( e.g. , corticosteroid ≥ 0.5 mg/kg/day ) immunomodulating treatment last six month screen visit 4 . Renal insufficiency ( creatinine clearance &lt; 30 mL/min ) 5 . Decompensated cirrhosis ( ChildPugh class C )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>HBV vaccination , immunity</keyword>
</DOC>